Angle plc (AGL) Ordinary 10p

Sell:13.50pBuy:14.00p0.75p (5.77%)

Prices delayed by at least 15 minutes
Sell:13.50p
Buy:14.00p
Change:0.75p (5.77%)
Prices delayed by at least 15 minutes
Sell:13.50p
Buy:14.00p
Change:0.75p (5.77%)
Prices delayed by at least 15 minutes

Company Information

About this company

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.

Key people

Andrew D. W. Newland
Chief Executive, Executive Director
Ian F. Griffiths
Chief Financial Officer, Finance Director, Executive Director, Company Secretary
Jan Groen
Non-Executive Independent Chairman of the Board
Joseph E. Eid
Non-Executive Independent Director
Brian Howlett
Non-Executive Senior Independent Director
Juliet Thompson
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    AGL
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    GB0034330679
  • Market cap
    £44.35m
  • Employees
    150
  • Shares in issue
    322.64m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.